- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Perception Ultrasound launches new system
Perception Ultrasound of Miami this month introduced BTS 2000, a new ultrasound system for the diagnosis and treatment of prostate cancer. Unveiled at the American Society for Therapeutic Radiology and Oncology meeting in San Antonio, the unit allows
Perception Ultrasound of Miami this month introduced BTS 2000, a new ultrasound system for the diagnosis and treatment of prostate cancer. Unveiled at the American Society for Therapeutic Radiology and Oncology meeting in San Antonio, the unit allows clinicians to take ultrasound images of the prostate and, if a tumor is detected, to proceed with brachytherapy. BTS 2000 can send images and data via the Internet, and has the ability to work with high-dose radiation techniques. Perception has already placed the unit at Cedars Medical Center in Miami. The company develops software-driven medical imaging systems, such as its Perception 5000 PC-based ultrasound scanner, which is based on Windows NT and uses software rather than hardware to control system parameters (SCAN 11/12/97).
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
